Furthermore, while we conducted a stratified analysis of GBM and LGG, we did not further subdivide LGG by WHO grade II vs. III or IDH status (IDH-mutant vs. IDH-wildtype) due to data limitations, which may influence LOX expression. This evidence concerns the gene LOX and glioblastoma.